In article number 2100091, Agata Blasiak, Christopher Chen, Dean Ho, and co-workers demonstrate a promising application of CURATE.AI – a scalable, mechanism-independent and indication-agnostic artificial intelligence platform, to rapidly predict antihypertensive treatment responses and identify optimal, personalized doses for improved outcomes.